Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells (Q38800444)

6 September 2017

title

Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells (English)

1 reference

6 September 2017

Dorota Hoja-Łukowicz

1 reference

6 September 2017

Małgorzata Pokrywka

1 reference

6 September 2017

Monika Bubka

1 reference

6 September 2017

Marcelina Janik

1 reference

6 September 2017

Ewa Pocheć

1 reference

6 September 2017

Anna Lityńska

1 reference

6 September 2017

publication date

22 January 2016

1 reference

Cell Biology International

6 September 2017

published in

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

428-438

1 reference

Diagnostic and Prognostic Role of Galectin 3 Expression in Cutaneous Melanoma

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Association of galectin-3 expression with melanoma progression and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Phenotypic identification of the redox dye methylene blue as an antagonist of heat shock response gene expression in metastatic melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Diagnostic utility of galectin-3 in thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Identification of galectin-3 as a factor in pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3: an open-ended story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

The role of galectin-3 in cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Dynamics of galectin-3 in the nucleus and cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Advances in the non-surgical treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Transient gene silencing of galectin‐3 suppresses pancreatic cancer cell migration and invasion through degradation of β‐catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

21 January 2018

Galectin-3 and the skin

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectins as modulators of tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

On the role of galectin-3 in cancer apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Regulation of tumor progression by extracellular galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 – A jack-of-all-trades in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Extracellular functions of galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Targeting metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Expression of galectins in cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

High serum galectin-3 in advanced melanoma: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Expression of galectin-3 modulates T-cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectins: structure, function and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10582

21 January 2018

Identifiers

DOI

10.1002/CBIN.10582

1 reference

6 September 2017

1 reference